文献速递肺血管病与心包/心肌炎心力衰竭与心肌病

美国肺动脉高压相关住院的趋势与结局:2001至2012年全国住院样本数据库分析

Trends and Outcomes of Pulmonary Arterial Hypertension-Related Hospitalizations in the United States: Analysis of the Nationwide Inpatient Sample Database From 2001 Through 2012.
PubMed 文献 · JAMA Cardiol · 2016-01-01

该研究分析美国全国住院样本数据库中2001至2012年以肺动脉高压(PAH)为主要出院诊断的成人住院资料,发现PAH相关住院例数显著下降,但次均住院费用增加2.7倍、住院时间延长,住院死亡率无显著变化,多种合并症及急性并发症与住院死亡和住院时间延长相关。

要点

  • PAH相关住院例数从2001年3177例降至2012年1345例。
  • 住院死亡率无显著变化,但住院时间从7.0天延长至7.6天。

核心结论

  • 美国PAH相关住院例数显著减少,但住院费用大幅增加且更多由Medicare承担。
  • 住院死亡率保持不变,住院时间延长。
  • 多种合并症和急性并发症与住院死亡风险增加及住院时间延长相关。

研究设计与样本

  • 基于美国全国住院样本(Nationwide Inpatient Sample)数据库的回顾性趋势分析。
  • 纳入2001年1月1日至2012年12月31日年龄≥18岁、以PAH为主要出院诊断的成人住院患者。

主要发现

  • PAH相关住院例数从2001年3177例降至2012年1345例(趋势P<.001)。
  • 住院时间从2001年均值7.0天(标准误0.5)延长至2012年7.6天(标准误0.6)(趋势P=.009)。
  • 住院死亡率从2001年7.8%(标准误1.1%)至2012年6.3%(标准误1.7%),趋势P=.54。
  • 合并症如糖尿病、高血压、冠心病、COPD、贫血、心律失常、充血性心力衰竭、急慢性肾病、电解质紊乱、肺炎、心源性休克及急性呼吸衰竭的占比均上升。

关键数值与推荐

  • 教学医院入院与住院时间延长(β=2.0,95%CI 1.3-1.6)及住院死亡风险增加(OR=1.5,95%CI 1.1-2.1)相关。
  • 心律失常与住院时间延长(β=1.8,95%CI 1.1-2.6)及死亡风险增加(OR=1.8,95%CI 1.4-2.4)相关。
  • 急性肾损伤与住院时间延长(β=5.0,95%CI 3.9-6.1)及死亡风险增加(OR=2.3,95%CI 1.7-3.2)相关。
  • 急性脑血管意外与住院时间延长(β=6.6,95%CI 1.9-11.3)及死亡风险增加(OR=6.7,95%CI 2.1-21.1)相关。
  • 急性呼吸衰竭与住院时间延长(β=6.2,95%CI 5.1-7.4)及死亡风险增加(OR=5.6,95%CI 4.2-7.5)相关。

临床怎么用

  • 临床应关注PAH住院患者合并症负担增加及住院费用上升的趋势。
  • 对合并心律失常、急性肾损伤、急性脑血管意外或急性呼吸衰竭的PAH住院患者应警惕住院死亡风险增高。
  • 充血性心力衰竭(OR=1.7,95%CI 1.3-2.2)、心源性休克(OR=5.4,95%CI 2.7-10.9)及水电解质紊乱(OR=1.9,95%CI 1.5-2.4)与住院死亡风险增加相关。

局限性

  • 原文未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Recent trends and outcomes of pulmonary arterial hypertension (PAH)-related hospitalization in adults in the United States are unknown. OBJECTIVE: To examine the characteristics of PAH-related hospitalizations. DESIGN, SETTING, AND PARTICIPANTS: We analyzed the National Inpatient Sample database for all adult patients (≥18 years old) with PAH as the principal discharge diagnosis from January 1, 2001, through December 31, 2012. MAIN OUTCOMES AND MEASURES: We analyzed the temporal trends in hospitalization rate, hospital charges, in-hospital mortality, length of hospitalization, and comorbidities pertaining to PAH-related hospitalizations. We also evaluated the predictors of in-hospital mortality and length of hospitalizations. RESULTS: The number of PAH-related hospitalizations per year in adults decreased significantly from 2001 through 2012 (3177 vs 1345, P for trend <.001). However, the mean hospital charge per admission increased 2.7-fold from 2001 through 2012 ($29 507 vs $79 607, P for trend <.001). There was a significant increase in each of these associated comorbid conditions: diabetes (4.6%-7.8%), hypertension (5.1%-17.1%), coronary artery disease (15.6%-22.3%), chronic obstructive pulmonary disease (14.4%-20.1%), anemia (12.4%-20.4%), cardiac dysrhythmias (21.7%-29.0%), congestive heart failure (40.7%-56.1%), acute (5.9%-20.1%) or chronic kidney disease (1.1%-16.4%), fluid and electrolyte imbalance (18.9%-35.3%), pneumonia (4.4%-6.3%), cardiogenic shock (0.5%-1.5%), and acute respiratory failure (4.3%-20.8%) from 2001 through 2012. The length of hospitalization increased (mean [SE], 7.0 [0.5] days in 2001 vs 7.6 [0.6] days in 2012, P for trend = .009), but in-patient mortality remained unchanged (7.8% [1.1%] in 2001 vs 6.3% [1.7%] in 2012, P for trend = .54). Admission to a teaching hospital (β coefficient for length of hospitalization, 2.0; 95% CI, 1.3-1.6; odds ratio [OR] for mortality, 1.5; 95% CI, 1.1-2.1), cardiac dysrhythmias (β coefficient, 1.8; 95% CI, 1.1-2.6; OR, 1.8; 95% CI, 1.4-2.4), acute kidney injury (β coefficient, 5.0; 95% CI, 3.9-6.1; OR, 2.3; 95% CI, 1.7-3.2), acute cerebrovascular accident (β coefficient, 6.6; 95% CI, 1.9-11.3; OR, 6.7; 95% CI, 2.1-21.1), and acute respiratory failure (β coefficient, 6.2; 95% CI, 5.1-7.4; OR, 5.6; 95% CI, 4.2-7.5) were associated with increased length of hospitalization and in-hospital mortality. Congestive heart failure (OR, 1.7; 95% CI, 1.3-2.2), cardiogenic shock (OR, 5.4; 95% CI, 2.7-10.9), and fluid and electrolyte imbalance (OR, 1.9; 95% CI, 1.5-2.4) were associated with increased in-hospital mortality but not length of hospitalization. CONCLUSIONS AND RELEVANCE: Analyses of temporal changes in PAH care reveal a significant decrease in PAH-related hospitalizations in the United States, but hospital charges have increased substantially and are increasingly being borne by Medicare. In-hospital mortality remains unchanged, but length of hospitalization has increased. This study should help identify the characteristics of patients with PAH that are associated with increased risk of in-hospital mortality and longer length of hospitalization.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Anand V, Roy SS, Archer SL, et al. Trends and Outcomes of Pulmonary Arterial Hypertension-Related Hospitalizations in the United States: Analysis of the Nationwide Inpatient Sample Database From 2001 Through 2012. JAMA Cardiol. 2016. PMID: 27851838. doi:10.1001/jamacardio.2016.3591

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。